Research Library
Curated Studies & Clinical Data
A growing library of peer-reviewed studies, clinical trial data, and systematic reviews organized by compound. Every citation is linked to its primary source.
GLP-1RA- and Incretin-Based Therapies Within Lifestyle Interventions for Adults with Overweight or Obesity: A Systematic Review and Meta-Analysis
Bruna-Mejias A, Valenzuela-Fuenzalida JJ, Oyanedel G, et al.
Nutrients, 2026;18(11)
Prescribing of GLP-1 and GIP/GLP-1 Receptor Agonists and Other Glucose-Lowering Drugs Requiring Special Caution in Elderly Japanese People With Type 2 Diabetes: A Preliminary Report
Sato M, Takemura R, Yuki M, et al.
Journal of clinical medicine research, 2026;18(5):292-300
Incretin-Based Drugs for Obesity: Common and Drug-Specific Reporting Patterns of Adverse Drug Reactions-A Comparative Disproportionality Analysis Using EudraVigilance Reports Integrating SmPC Data
Popa Ilie IR, Ghibu S, Butuca A, et al.
Pharmaceuticals (Basel, Switzerland), 2026;19(6)
Impact of Semaglutide on Hippocampal Injury in a Streptozotocin-Induced Model of Alzheimer’s Disease
Stavrovskaya AV, Pavlova AK, Voronkov DN, et al.
Biomedicines, 2026;14(6)
Incretin-Based Therapies in Obesity-Related Heart Failure With Preserved Ejection Fraction (HFpEF): A Systematic Review of Emerging Cardiometabolic Disease Modification Beyond Glycemic Control
Hemdev V, Abuzenah M, Alsaafin Q, et al.
Cureus, 2026;18(5):e109953
BPC-157 and Its Novel Hybrid Analogs as Inhibitors of Acetylcholinesterase
Jelińska J, Józwiak M, Szeleszczuk Ł, et al.
International journal of molecular sciences, 2026;27(11)
Unilateral Adrenalectomy, and the Stable Pentadecapeptide BPC 157 as Therapy in Rats-A Cytoprotection Approach
Smoday IM, Vukovic V, Oroz K, et al.
Pharmaceuticals (Basel, Switzerland), 2026;19(6)
Prolonged Dysesthesia After Massive Accidental Semaglutide Overdose: A Case Report
Quarenghi M, Stanga A, Bergamaschi A
Journal of the American College of Emergency Physicians open, 2026;7(4):100427
Nutrition-First Support for GLP-1 and Dual Incretin Therapy in Obesity: A Practical Framework for Dietary Management, Symptom Tolerability, and Long-Term Weight Maintenance
Zambrano-Villacres R, Campuzano-Donoso M, Reytor-González C, et al.
Nutrients, 2026;18(11)
Turning back time: a comprehensive list of interventions that decrease next-generation epigenetic aging clocks in humans
Johnson AA, Sinclair DA
Frontiers in genetics, 2026;17:1836446
Activation of GLP-1R ameliorates alcohol withdrawal induced anxiety-like behavior by regulating neuronal mitochondrial quality control
Wang Z, Zhao W, Chen X, et al.
Frontiers in pharmacology, 2026;17:1820128
Formulation Engineering of Oral Semaglutide Tablets: Unleashing Gastric Intestinal Permeation with Sodium Caprate
Kim DH, Hwang SK, Yoon JH, et al.
Pharmaceutics, 2026;18(6)
Akkermansia muciniphila and GLP-1-Based Therapies: Bidirectional Interactions and Implications for Type 2 Diabetes and MASLD/MASH
Dinkov B
Biomedicines, 2026;14(6)
Protective effects of BPC 157 in rats with experimentally induced lower extremity ischemia-reperfusion injury
Yıldırım AK, Demirtaş H, Özer A, et al.
Scientific reports, 2026
LCP2 mediates SUV39H1-driven cellular senescence-related chemoresistance in natural killer/T-cell lymphoma
Zhang Y, Qian S, Yang Q, et al.
Cell death & disease, 2026
Spinal Implant-Associated Infection in Type 2 and Type 1 Diabetes: Phenotype-Specific Inflammatory Features and Therapeutic Response to Semaglutide
Olson TE, Lloyd TS, Hamad CD, et al.
JOR spine, 2026;9(2):e70196
Inter-organ communication shapes human metabolic tissue states and resolves anti-diabetic drug response modes in a six-tissue microphysiological system
McGilvrey M, Chew S, Siddiqui MF, et al.
bioRxiv : the preprint server for biology, 2026
Lean Mass and Musculoskeletal Preservation in GLP-1-Based Obesity Treatment: Nutrition, Exercise, Supplementation, and Monitoring Strategies
Šantić R, Martinović L, Pavlović N, et al.
Metabolites, 2026;16(6)
Middle-aged mice treated with GHK-Cu peptide administered intraperitoneally or intranasally show behavioral rescue but divergent hippocampal aging programs
Mazzola J, Rosenfeld M, Tucker M, et al.
Research square, 2026
Evaluation of the Efficacy of Semaglutide Dose Escalation in Reducing HbA1c Levels and Insulin Dose in Type 2 Diabetes Patients: Real-World Semaglutide Data from Türkiye, SEMA-TR Study
Sumbul HE, Isik B, Mustan AG, et al.
Journal of clinical medicine, 2026;15(11)